RIR1_HUMAN - dbPTM
RIR1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RIR1_HUMAN
UniProt AC P23921
Protein Name Ribonucleoside-diphosphate reductase large subunit
Gene Name RRM1
Organism Homo sapiens (Human).
Sequence Length 792
Subcellular Localization Cytoplasm.
Protein Description Provides the precursors necessary for DNA synthesis. Catalyzes the biosynthesis of deoxyribonucleotides from the corresponding ribonucleotides..
Protein Sequence MHVIKRDGRQERVMFDKITSRIQKLCYGLNMDFVDPAQITMKVIQGLYSGVTTVELDTLAAETAATLTTKHPDYAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRPAANPIQFTLNKEKLKDKEKVSKEEEEKERNTAAMVCSLENRDECLMCGS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
5Ubiquitination---MHVIKRDGRQER
---CCEECCCCCCHH
43.26-
172-HydroxyisobutyrylationQERVMFDKITSRIQK
CHHHCHHHHHHHHHH
36.30-
17AcetylationQERVMFDKITSRIQK
CHHHCHHHHHHHHHH
36.3019608861
17UbiquitinationQERVMFDKITSRIQK
CHHHCHHHHHHHHHH
36.3021890473
24AcetylationKITSRIQKLCYGLNM
HHHHHHHHHHHCCCC
37.8525953088
24UbiquitinationKITSRIQKLCYGLNM
HHHHHHHHHHHCCCC
37.8521906983
70UbiquitinationTAATLTTKHPDYAIL
HHHHHCCCCCCHHHH
48.15-
74PhosphorylationLTTKHPDYAILAARI
HCCCCCCHHHHHHHH
10.45-
80MethylationDYAILAARIAVSNLH
CHHHHHHHHHHHHHC
16.28115492899
882-HydroxyisobutyrylationIAVSNLHKETKKVFS
HHHHHHCHHHHHHHH
70.96-
88UbiquitinationIAVSNLHKETKKVFS
HHHHHHCHHHHHHHH
70.96-
92UbiquitinationNLHKETKKVFSDVME
HHCHHHHHHHHHHHH
56.8021906983
102PhosphorylationSDVMEDLYNYINPHN
HHHHHHHHHHHCCCC
20.4517360941
104PhosphorylationVMEDLYNYINPHNGK
HHHHHHHHHCCCCCC
6.6317360941
111UbiquitinationYINPHNGKHSPMVAK
HHCCCCCCCCCCHHH
46.3421906983
113PhosphorylationNPHNGKHSPMVAKST
CCCCCCCCCCHHHHH
20.4120068231
118UbiquitinationKHSPMVAKSTLDIVL
CCCCCHHHHHHHEEE
32.34-
119PhosphorylationHSPMVAKSTLDIVLA
CCCCHHHHHHHEEEE
25.1928450419
120PhosphorylationSPMVAKSTLDIVLAN
CCCHHHHHHHEEEEC
27.9528450419
1282-HydroxyisobutyrylationLDIVLANKDRLNSAI
HHEEEECHHHCCEEE
38.32-
128UbiquitinationLDIVLANKDRLNSAI
HHEEEECHHHCCEEE
38.3221906983
133PhosphorylationANKDRLNSAIIYDRD
ECHHHCCEEEEECCC
25.9923312004
137PhosphorylationRLNSAIIYDRDFSYN
HCCEEEEECCCCCCC
9.9820068231
142PhosphorylationIIYDRDFSYNYFGFK
EEECCCCCCCCCCCE
19.4321712546
149UbiquitinationSYNYFGFKTLERSYL
CCCCCCCEECCEEEE
53.2121906983
154PhosphorylationGFKTLERSYLLKING
CCEECCEEEEEEECC
15.6824719451
155PhosphorylationFKTLERSYLLKINGK
CEECCEEEEEEECCE
23.4424719451
158UbiquitinationLERSYLLKINGKVAE
CCEEEEEEECCEECC
31.3721890473
162UbiquitinationYLLKINGKVAERPQH
EEEEECCEECCCCCE
33.51-
180UbiquitinationRVSVGIHKEDIDAAI
EEEECCCHHHHHHHH
55.9821906983
202PhosphorylationERWFTHASPTLFNAG
HHHCCCCCCCCCCCC
15.7121601212
232PhosphorylationDDSIEGIYDTLKQCA
CCCHHHHHHHHHHHH
17.4628796482
234PhosphorylationSIEGIYDTLKQCALI
CHHHHHHHHHHHHHH
20.9128796482
236UbiquitinationEGIYDTLKQCALISK
HHHHHHHHHHHHHHH
45.4821906983
243AcetylationKQCALISKSAGGIGV
HHHHHHHHCCCCCHH
37.0126051181
243UbiquitinationKQCALISKSAGGIGV
HHHHHHHHCCCCCHH
37.01-
253O-linked_GlycosylationGGIGVAVSCIRATGS
CCCHHHHEEEEECCC
8.2928510447
253PhosphorylationGGIGVAVSCIRATGS
CCCHHHHEEEEECCC
8.2921712546
2922-HydroxyisobutyrylationYVDQGGNKRPGAFAI
EECCCCCCCCCEEEE
64.34-
320"N6,N6-dimethyllysine"DLKKNTGKEEQRARD
CHHCCCCCHHHHHHH
56.91-
320MethylationDLKKNTGKEEQRARD
CHHCCCCCHHHHHHH
56.9123644510
320UbiquitinationDLKKNTGKEEQRARD
CHHCCCCCHHHHHHH
56.91-
369UbiquitinationVWGEEFEKLYASYEK
HHHHHHHHHHHHHHH
52.71-
3762-HydroxyisobutyrylationKLYASYEKQGRVRKV
HHHHHHHHCCCHHHH
50.23-
376AcetylationKLYASYEKQGRVRKV
HHHHHHHHCCCHHHH
50.2319608861
376UbiquitinationKLYASYEKQGRVRKV
HHHHHHHHCCCHHHH
50.2321890473
414UbiquitinationYKDSCNRKSNQQNLG
EECCCCCCCCCCCCC
39.5021906983
415PhosphorylationKDSCNRKSNQQNLGT
ECCCCCCCCCCCCCC
36.3125159151
422PhosphorylationSNQQNLGTIKCSNLC
CCCCCCCCCEECCHH
22.0420068231
424UbiquitinationQQNLGTIKCSNLCTE
CCCCCCCEECCHHHH
31.30-
437PhosphorylationTEIVEYTSKDEVAVC
HHHHHCCCCCCHHHH
36.8921601212
464UbiquitinationSEHTYDFKKLAEVTK
CCCCCCHHHHHHHHH
43.94-
465UbiquitinationEHTYDFKKLAEVTKV
CCCCCHHHHHHHHHH
53.5821906983
4712-HydroxyisobutyrylationKKLAEVTKVVVRNLN
HHHHHHHHHHHCCCH
37.90-
471UbiquitinationKKLAEVTKVVVRNLN
HHHHHHHHHHHCCCH
37.9021906983
479UbiquitinationVVVRNLNKIIDINYY
HHHCCCHHCCCEEEE
44.18-
485PhosphorylationNKIIDINYYPVPEAC
HHCCCEEEEECCHHH
14.9628152594
486PhosphorylationKIIDINYYPVPEACL
HCCCEEEEECCHHHH
8.0228152594
494PhosphorylationPVPEACLSNKRHRPI
ECCHHHHCCCCCCCC
39.9428152594
496AcetylationPEACLSNKRHRPIGI
CHHHHCCCCCCCCCC
46.3223954790
496UbiquitinationPEACLSNKRHRPIGI
CHHHHCCCCCCCCCC
46.3221906983
548UbiquitinationEASCDLAKEQGPYET
HHHCHHHHHHCCCCC
58.84-
553PhosphorylationLAKEQGPYETYEGSP
HHHHHCCCCCCCCCC
27.9428152594
555PhosphorylationKEQGPYETYEGSPVS
HHHCCCCCCCCCCCC
22.4928152594
556PhosphorylationEQGPYETYEGSPVSK
HHCCCCCCCCCCCCC
13.3228152594
559PhosphorylationPYETYEGSPVSKGIL
CCCCCCCCCCCCCEE
15.3628152594
563UbiquitinationYEGSPVSKGILQYDM
CCCCCCCCCEEEEEC
50.64-
582UbiquitinationPTDLWDWKVLKEKIA
CCCCCCHHHHHHHHH
34.91-
587UbiquitinationDWKVLKEKIAKYGIR
CHHHHHHHHHHHCCC
46.51-
590AcetylationVLKEKIAKYGIRNSL
HHHHHHHHHCCCCCE
47.7025953088
590UbiquitinationVLKEKIAKYGIRNSL
HHHHHHHHHCCCCCE
47.7021890473
596PhosphorylationAKYGIRNSLLIAPMP
HHHCCCCCEEEEECC
18.0724144214
604PhosphorylationLLIAPMPTASTAQIL
EEEEECCCCCHHHHH
27.3021712546
606O-linked_GlycosylationIAPMPTASTAQILGN
EEECCCCCHHHHHCC
27.1028510447
606PhosphorylationIAPMPTASTAQILGN
EEECCCCCHHHHHCC
27.1024144214
607PhosphorylationAPMPTASTAQILGNN
EECCCCCHHHHHCCC
21.8124144214
616PhosphorylationQILGNNESIEPYTSN
HHHCCCCCCCCCCCC
34.0824144214
620PhosphorylationNNESIEPYTSNIYTR
CCCCCCCCCCCCCEE
15.2624144214
621PhosphorylationNESIEPYTSNIYTRR
CCCCCCCCCCCCEEC
26.4724144214
622PhosphorylationESIEPYTSNIYTRRV
CCCCCCCCCCCEECC
18.5224144214
625PhosphorylationEPYTSNIYTRRVLSG
CCCCCCCCEECCCCC
9.8424144214
626PhosphorylationPYTSNIYTRRVLSGE
CCCCCCCEECCCCCC
14.2724144214
631PhosphorylationIYTRRVLSGEFQIVN
CCEECCCCCCCEEEC
33.1628450419
643UbiquitinationIVNPHLLKDLTERGL
EECHHHHHHHHHCCC
57.9921890473
655SulfoxidationRGLWHEEMKNQIIAC
CCCCCHHHHHCEEEE
4.5030846556
656UbiquitinationGLWHEEMKNQIIACN
CCCCHHHHHCEEEEC
49.32-
677UbiquitinationPEIPDDLKQLYKTVW
CCCCHHHHHHHHHHH
45.30-
681UbiquitinationDDLKQLYKTVWEISQ
HHHHHHHHHHHHHCH
45.2321906983
682O-linked_GlycosylationDLKQLYKTVWEISQK
HHHHHHHHHHHHCHH
19.7928510447
689AcetylationTVWEISQKTVLKMAA
HHHHHCHHHHHHHHH
33.5325953088
689UbiquitinationTVWEISQKTVLKMAA
HHHHHCHHHHHHHHH
33.5321906983
693AcetylationISQKTVLKMAAERGA
HCHHHHHHHHHHCCC
23.3526051181
693UbiquitinationISQKTVLKMAAERGA
HCHHHHHHHHHHCCC
23.3521906983
721PhosphorylationEPNYGKLTSMHFYGW
CCCCCCCEEEEECCC
27.7324719451
722PhosphorylationPNYGKLTSMHFYGWK
CCCCCCEEEEECCCC
22.2428348404
726PhosphorylationKLTSMHFYGWKQGLK
CCEEEEECCCCCCCC
13.8529978859
729AcetylationSMHFYGWKQGLKTGM
EEEECCCCCCCCCEE
30.0825953088
729UbiquitinationSMHFYGWKQGLKTGM
EEEECCCCCCCCCEE
30.08-
733UbiquitinationYGWKQGLKTGMYYLR
CCCCCCCCCEEEEEC
50.27-
734O-linked_GlycosylationGWKQGLKTGMYYLRT
CCCCCCCCEEEEECC
32.0228510447
734PhosphorylationGWKQGLKTGMYYLRT
CCCCCCCCEEEEECC
32.0221406692
737PhosphorylationQGLKTGMYYLRTRPA
CCCCCEEEEECCCCC
10.7421406692
738PhosphorylationGLKTGMYYLRTRPAA
CCCCEEEEECCCCCC
4.8421406692
741PhosphorylationTGMYYLRTRPAANPI
CEEEEECCCCCCCCE
38.1121406692
751PhosphorylationAANPIQFTLNKEKLK
CCCCEEEEECHHHHC
17.0425159151
754AcetylationPIQFTLNKEKLKDKE
CEEEEECHHHHCCHH
60.3826051181
754UbiquitinationPIQFTLNKEKLKDKE
CEEEEECHHHHCCHH
60.3821890473
756UbiquitinationQFTLNKEKLKDKEKV
EEEECHHHHCCHHHC
63.55-
762UbiquitinationEKLKDKEKVSKEEEE
HHHCCHHHCCHHHHH
58.51-
764O-linked_GlycosylationLKDKEKVSKEEEEKE
HCCHHHCCHHHHHHH
45.4728510447
765UbiquitinationKDKEKVSKEEEEKER
CCHHHCCHHHHHHHH
72.61-
770UbiquitinationVSKEEEEKERNTAAM
CCHHHHHHHHHHHHH
66.31-
774PhosphorylationEEEKERNTAAMVCSL
HHHHHHHHHHHHHCC
23.2421712546
780O-linked_GlycosylationNTAAMVCSLENRDEC
HHHHHHHCCCCCCCC
27.5828510447
780PhosphorylationNTAAMVCSLENRDEC
HHHHHHHCCCCCCCC
27.5822617229
792PhosphorylationDECLMCGS-------
CCCCCCCC-------
31.9229978859

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseRNF2Q99496
PMID:24614341
-KUbiquitinationE3 ubiquitin ligaseBMI1P35226
PMID:24614341

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RIR1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RIR1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RIR2_HUMANRRM2physical
14583450
RIR2B_HUMANRRM2Bphysical
14583450
LRIF1_HUMANLRIF1physical
16169070
RIR1_HUMANRRM1physical
11781084
RIR2_HUMANRRM2physical
11781084
KAT5_HUMANKAT5physical
20159953
RIR2_HUMANRRM2physical
20159953
RIR2B_HUMANRRM2Bphysical
20159953
SPHM_HUMANSGSHphysical
22939629
SUCB1_HUMANSUCLA2physical
22939629
TM177_HUMANTMEM177physical
22939629
TNPO1_HUMANTNPO1physical
22863883
RING2_HUMANRNF2physical
24614341
BMI1_HUMANBMI1physical
24614341
RIR1_HUMANRRM1physical
25416956
RIR2_HUMANRRM2physical
26344197
MDM2_HUMANMDM2physical
26228206
RIR2B_HUMANRRM2Bphysical
28514442
GLRX3_HUMANGLRX3physical
28514442
RIR2_HUMANRRM2physical
28514442
ARL5B_HUMANARL5Bphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RIR1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17 AND LYS-376, AND MASSSPECTROMETRY.

TOP